EMC
89
4
CNP
52
3
SRE
52
2
O
46
-2
CHK
34
3
BBY
50
4
LH
55
5
JWN
72
3
STX
57
4
TMO
66
3
PPG
72
2
JBHT
45
3
EA
52
2
YUM
62
4
CI
69
6
HCA
59
9
KMX
57
2
LOW
64
2
GLW
75
3
MCK
75
2
EMC
89
4
CNP
52
3
SRE
52
2
O
46
-2
CHK
34
3
BBY
50
4
LH
55
5
JWN
72
3
STX
57
4
TMO
66
3
PPG
72
2
JBHT
45
3
EA
52
2
YUM
62
4
CI
69
6
HCA
59
9
KMX
57
2
LOW
64
2
GLW
75
3
MCK
75
2
Financhill
Back

Arcturus Therapeutics Holdings Quote, Financials, Valuation and Earnings

MarketBeat Alert: Strong sell signal just issued for these 20 stocks

Go here now to get free instant access to all 20 stocks to sell.
Sell
44

ARCT
Arcturus Therapeutics Holdings

Last Price:
26.94
Seasonality Move:
27.82%

7 Day Trial

ALL ACCESS PASS

$ 7

I love this overnight trade happening Thursday

Access my free presentation on these overnight trades right here

Arcturus Therapeutics Holdings Price Quote

$26.94
+0.15 (+0.56%)
(Updated: May 10, 2024 at 12:40 PM ET)

Arcturus Therapeutics Holdings Key Stats

Sell
44
Arcturus Therapeutics Holdings (ARCT) is a Sell
Day range:
$26.28 - $29.08
52-week range:
$17.52 - $43.81
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.47
P/B ratio:
2.73%
Volume:
547.9K
Avg. volume:
498K
1-year change:
-7.46%
Market cap:
$721.5M
Revenue:
$157.7M
EPS:
$-3.91

How Much Does Arcturus Therapeutics Holdings Make?

Is Arcturus Therapeutics Holdings Growing As A Company?

Arcturus Therapeutics Holdings Stock Price Performance

What Is Arcturus Therapeutics Holdings 52-Week High & Low?

Arcturus Therapeutics Holdings Price To Free Cash Flow

Is It Risky To Buy Arcturus Therapeutics Holdings?

Is Arcturus Therapeutics Holdings Cash Flow Positive?

Arcturus Therapeutics Holdings Return On Invested Capital

  • Is Management Doing A Good Job?
    ARCT return on invested capital is -36.82%
  • What Is Arcturus Therapeutics Holdings Return On Assets?
    ROA measures how assets are converting to revenues and is -24.3%
  • What Is ARCT Return On Equity?
    ROE is a measure of profitability and is -37.33%

Arcturus Therapeutics Holdings Earnings Date & Stock Price

Arcturus Therapeutics Holdings Competitors

Arcturus Therapeutics Holdings Dividend Yield

Data Unavailable

Arcturus Therapeutics Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 12.59%
Revenue: -59.11% 115.09%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 0
Sell Recommendations: 1
Price Target: 67.89
Upside from Last Price: 153.41%

Major Shareholders

  • How many ARCT shares are owned by institutional investors?
    49.1M ARCT shares are owned by institutional investors
  • How many ARCT shares are owned by insiders?
    2.3M ARCT shares are owned by insiders